1083300-23-5

Basic information

• Product Name: 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl-
• Synonyms: 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl-;5-Methyl-1,2,4-oxadiazole-3-carbaldehyde;5-methyl-1,2,4-Oxadiazole-3-carboxaldehyde
• CAS NO: 1083300-23-5
• Molecular Formula: C₄H₄N₂O₂
• Molecular Weight: 112.08676
• Mol File: 1083300-23-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 224.2±23.0 °C(Predicted)
• Appearance: /
• Density: 1.294±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -2.17±0.10(Predicted)
• CAS DataBase Reference: 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl-(1083300-23-5)
• EPA Substance Registry System: 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl-(1083300-23-5)

Safety Data

• Hazardous Substances Data: 1083300-23-5(Hazardous Substances Data)

Usage

General Description

1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl- is a chemical compound with the molecular formula C5H5N3O2. It is a derivative of oxadiazole and is characterized by a five-membered ring containing one oxygen and two nitrogen atoms. 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl- is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various medicinal drugs. It is also used in chemical research for its unique properties and potential applications in the development of new compounds. Overall, 1,2,4-Oxadiazole-3-carboxaldehyde, 5-Methyl- is an important chemical with diverse uses in the pharmaceutical and research fields.

Upstream product

• 25977-23-5 (5-methyl-1,2,4-oxadiazol-3-yl)methanol 

Downstream Products

• 1104599-59-8 3-((1S,3R)-3-(4-(4-fluorophenyl)-1H-imidazol-2-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-5-methyl-1,2,4-oxadiazole 
• 1104604-50-3 3-((1R,3R)-3-(4-(4-fluorophenyl)-1H-imidazol-2-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-5-methyl-1,2,4-oxadiazole 

Relevant articles and documents

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.